Jeff Fox’s Blog
What Do Proposed Macro Changes Signal For Brokers in 2024 and Beyond?
With Q1 2024 already nearly complete, the brokerage market remains focused on its projected growth to $628.3 billion by 2032. For now, however, brokers and their commissions have grappled with evolving trends and regulatory shifts. [...]
Renal Replacement Therapies Beyond Dialysis
Renal replacement therapy, a life-sustaining treatment for individuals with end-stage renal disease (ESRD), traditionally revolves around hemodialysis and peritoneal dialysis. However, the limitations and burdens associated with these methods have prompted the exploration of cutting-edge [...]
How Has the Post-COVID US Healthcare System Changed on Behalf of Chronic Disease?
Now that COVID-19 has regressed in terms of being an active economic, social, and existential hindrance, the US has finally transitioned to implementing key lessons learned during the pandemic and circumventing ongoing issues stemming from [...]
Value-Based Healthcare Methodologies For Chronic Kidney Disease in 2024
As healthcare grows to embrace value-based solutions, the chronic kidney disease (CKD) sector is one of several concentrations standing to reap immense benefits from such methodology. Broadly speaking, potential value-based assets for CKD include, but [...]
Leveraging Sales Distribution Management Software For Success
Today, many prominent industries rely, in some manner, on high-quality, strategic sales distribution management. For healthcare brokers – namely, those selling Medicare plans – this process gives way to a complex landscape posing myriad challenges [...]
BPO Offerings in Medicare
Business Process Outsourcing (BPO) has become a game-changer within healthcare – as reflected by the market’s current projected growth (it stands to eclipse $468.5 billion in the near future). Specifically, the BPO industry holds vast [...]